aXichem AB (FRA:A6X)

Market Cap	12.13M
Revenue (ttm)	1.45M
Net Income (ttm)	-1.60M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1510
Previous Close	0.1585
Day's Range	0.1510 - 0.1510
52-Week Range	0.0570 - 0.3230
Beta	n/a
RSI	50.92
Earnings Date	Feb 26, 2026

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is b...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A6X

Financial Performance

In 2024, aXichem AB's revenue was 8.57 million, an increase of 373.74% compared to the previous year's 1.81 million. Losses were -17.81 million, -14.41% less than in 2023.

Financial numbers in SEK